Found 478 clinical trials
Correlation Between TILs and Blood Cell Counts in Triple Negative Breast Cancer Patients (PERCEPTION)
-Lymphocyte Ratio)) and Tumor Infiltrating Lymphocytes (TILs), at baseline and after surgery, for patients diagnosed with triple negative breast cancer. It also aims to assess these circulating elements and
- 1 views
- 27 Jun, 2022
- 1 location
CTC Changes and Efficacy of Neoadjuvant Chemotherapy for Triple-negative Breast Cancer
chemotherapeutic drugs and create opportunities for breast-conserving or surgical treatment for patients. This may lead to high survival opportunities for triple-negative breast cancer patients who are not
- 1 views
- 25 Mar, 2022
- 2 locations
Treatment Decision Making in African American Women Diagnosed With Triple Negative Breast Cancer
This study evaluates what influences treatment decision-making in African American women with triple negative breast cancer. The study also aims to learn about the influence of information
- 0 views
- 21 Mar, 2022
- 1 location
TRIple Negative Breast Cancer Markers In Liquid Biopsies Using Artificial Intelligence
Triple negative breast cancer (TNBC) is the most aggressive of breast cancers and it is usually treated with chemotherapy even before surgery. In many cases, the chemotherapy completely "melts
- 0 views
- 14 May, 2021
- 4 locations
Evaluation of a Plasma Protein Profile as a Predictive Biomarker for Metastatic Relapse in Triple Negative Breast Cancer Patients (INSTIGO)
The INSTIGO study aims to assess a plasma protein profile at different stages of patient follow-up as a predictive factor of metastatic recurrence in triple negative breast cancer. It also aims
- 0 views
- 23 Mar, 2022
- 1 location
De-convoluting Interactions Between Genes, the Cancer Environment, and the Immune System to Develop Therapies That Work for You (DIGNITY)
This is a live biobank study for Triple negative breast cancer (TNBC) patients where samples will be collected at inflection points in the course of the disease.
- 0 views
- 24 Apr, 2022
- 2 locations
Predictors of Response to Neoadjuvant Docetaxel-Carboplatin Chemotherapy for Patients With Stage II and III Triple Negative Breast Cancer
performed using FFEP tissue. Triple Negative Breast Cancer (TNBC) is defined by a lack of expression of ER, PgR and HER-2. DNA microarray profiling studies have led to the classification of invasive
- 0 views
- 04 Sep, 2021
- 1 location
Comparison of the Breast Tumor Microenvironment
receiving intraoperative radiation therapy (IORT) in subjects that have luminal A and triple negative breast cancer. IORT is considered as being standard of care.
- 1 views
- 02 Sep, 2021
- 1 location
Brain Monitoring for High Risk of Brain Metastases in Metastatic Breast Cancer
Imaging) can detect early brain metastases and influence survival through early brain management in HER2-positive and triple negative breast cancer.
- 0 views
- 26 Jan, 2021
- 1 location
Multiparametric MRI as a Non-Invasive Biomarker of the Tumor Microenviroment
This study is looking at how an imaging test could help doctors understand if a patient with early breast cancer will respond to drugs that use the patient's immune system to fight cancer.
- 0 views
- 19 Apr, 2022
- 1 location